Phio Pharmaceuticals

(NASDAQ) PHIO

Current Price$1.12

Market Cap$13.01M

Since IPO (2012)-100%

5 Year-99%

1 Year-40%

1 Month-13%

Phio Pharmaceuticals Financials at a Glance

Market Cap

$13.01M

Revenue (TTM)

$0.00

Net Income (TTM)

$10.93M

EPS (TTM)

$-1.44

P/E Ratio

-0.78

Dividend

$0.00

Beta (Volatility)

0.95 (Low)

Dividend

$0.00

Beta (Volatility)

0.95 (Low)

Price

$1.12

Volume

Open

$1.14

Price

$1.12

Volume

Open

$1.14

Previous Close

$1.12

Daily Range

$1.11 - $1.15

52-Week Range

$0.81 - $4.19

Dividend

$0.00

Beta (Volatility)

0.95 (Low)

Price

$1.12

Volume

Open

$1.14

Previous Close

$1.12

Daily Range

$1.11 - $1.15

52-Week Range

$0.81 - $4.19

PHIO News

Phio Posts Wider Loss in Fiscal Q2

Motley Fool Markets TeamAug 14, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Phio Pharmaceuticals

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Robert J. Bitterman, Sr., MBA

Website

www.phiopharma.com

Headquarters

Marlborough, MA 01752, US

PHIO Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-76%

Return on Capital

-67%

Return on Assets

-63%

Earnings Yield

-1.28%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$13.01M

Shares Outstanding

11.62M

Volume

Avg. Volume

391.10K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$9.22M

EBITDA

$9.22M

Operating Cash Flow

$7.98M

Capital Expenditure

$12.00K

Free Cash Flow

$7.99M

Cash & ST Invst.

$21.03M

Total Debt

$0.00

Phio Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$1.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$13.01M

N/A

Market Cap/Employee

$2.60M

N/A

Employees

N/A

Net Income

$4.00M

-126.3%

EBITDA

$4.17M

-135.5%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$17.03M

+28.3%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-62.78%

N/A

Return on Invested Capital

-67.14%

N/A

Free Cash Flow

$4.00M

-213.5%

Operating Cash Flow

$4.00M

-214.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

KPRXKiora Pharmaceuticals, Inc.

KPRXKiora Pharmaceuticals, Inc.$2.58-4.09%

MRKRMarker Therapeutics, Inc.

MRKRMarker Therapeutics, Inc.$1.46+2.10%

APVOAptevo Therapeutics Inc.

APVOAptevo Therapeutics Inc.$4.79+0.74%

INABIN8bio, Inc.

INABIN8bio, Inc.$1.59+0.00%

BCDABioCardia, Inc.

BCDABioCardia, Inc.$1.09+1.87%

RNAZTransCode Therapeutics, Inc.

RNAZTransCode Therapeutics, Inc.$6.79-2.60%

APREAprea Therapeutics, Inc.

APREAprea Therapeutics, Inc.$0.94+6.93%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$16.65-0.01%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$41.07-0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$78.95+0.02%

AIIORobo.ai

AIIORobo.ai$5.64+1.16%

ONDSOndas

ONDSOndas$11.21+0.27%

SOFISoFi Technologies

SOFISoFi Technologies$16.02+0.05%

EOSEEos Energy Enterprises

EOSEEos Energy Enterprises$8.17-0.01%

Questions About PHIO

What is the current price of Phio Pharmaceuticals?

Phio Pharmaceuticals is trading at $1.12 per share.

What is the 52-week range for Phio Pharmaceuticals?

Over the past 52 weeks, Phio Pharmaceuticals has traded between $0.81 and $4.19.

How much debt does Phio Pharmaceuticals have?

As of the most recent reporting period, Phio Pharmaceuticals reported total debt of N/A.

How much cash does Phio Pharmaceuticals have on hand?

Phio Pharmaceuticals reported $17.03M in cash and cash equivalents in its most recent financial results.

What is Phio Pharmaceuticals’s dividend yield?

Phio Pharmaceuticals does not currently have a dividend yield.

Phio Pharmaceuticals

Phio Pharmaceuticals Financials at a Glance

PHIO News

Phio Posts Wider Loss in Fiscal Q2

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Phio Pharmaceuticals

PHIO Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Phio Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About PHIO

What is the current price of Phio Pharmaceuticals?

What is the 52-week range for Phio Pharmaceuticals?

How much debt does Phio Pharmaceuticals have?

How much cash does Phio Pharmaceuticals have on hand?

What is Phio Pharmaceuticals’s dividend yield?

Premium Investing Services